ArticleHealth science reports2026
Persistent Neurological Symptoms in Chronic Disease Patients After COVID-19 Infection in Jamaica: A Retrospective Cohort Study Exploring Clinical Manifestations of Long COVID in a Low and Middle Income Country.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: There is uncertainty about the long term effects of COVID-19 infection. We describe the dominant reported symptoms and their sociodemographic risk factors in a sample of Jamaican patients with non-communicable diseases (NCD) and laboratory determined infection status. Methods: A retrospective cohort study (February 20, 2023-September 12, 2023) of patients from the University Hospital of the West Indies (UHWI) were identified through participation in the Caribbean COVID-19 Metabolic Health Study (CCMHS) or ICU admissions between March 2020 and March 2021 with a positive PCR. COVID-19 infection status was based on anti-nucleocapsid (anti-N) antibodies in those without PCR reports. Participants were classified as "Exposed" if they had positive anti-N antibodies or a positive PCR test and "Unexposed" if they had negative anti-N antibodies. Bivariate analyses compared current symptoms and quality of life of exposed and unexposed participants. Logistic regression explored factors associated with memory loss. Results: Eighty-six persons (62 exposed and 24 unexposed; mean age 54.1 ± 13.4 years; median "time since first COVID-19 diagnosis" 1.9 years) participated in the study. "Not [feeling] quite right" (59.3%), joint pains (46.5%), fatigue (45.4%), numbness/tingling (43.0%), headache (26.7%), and shortness of breath (23.3%) were the most common symptoms that were similarly reported in persons regardless of infection status. Memory loss was more common among exposed participants (41.9% vs. 12.5%, Conclusion: Cardiopulmonary and musculoskeletal symptoms were common among NCD patients regardless of previous COVID-19 infection. However, memory loss was more common up to 2 years after initial COVID-19 infection. Prospective cohorts of long COVID in subpopulations are critical to elucidating its natural history.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.